Publicerat: 2021-06-11 10:59:41
Redeye leaves a short comment on Calmark following the announcement of an Indian distribution agreement for its COVID-19 LDH test. We view this as another value-enhancing activity and feel encouraged by the recent newsflow from the company.
Länk till analysen